Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data

British Medical Journal

Volumn 325, Issue 7372, 2002, Pages 1070-1072

  Hennessy, Scan ^a   Bilker, Warren B ^a   Knauss, Jill S ^a   Margolis, David J ^a   Kimmel, Stephen E ^a   Reynolds, Robert F ^b   Glasser, Dale B ^b   Morrison, Mary F ^a   Strom, Brian L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE; THIORIDAZINE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLAUCOMA; HEART ARREST; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; SCHIZOPHRENIA;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; ARRHYTHMIA; CLOZAPINE; COHORT STUDIES; CONFIDENCE INTERVALS; DEATH, SUDDEN, CARDIAC; FEMALE; HALOPERIDOL; HEART ARREST; HUMANS; MALE; MEDICAID; MIDDLE AGED; RISPERIDONE; SCHIZOPHRENIA; THIORIDAZINE; UNITED STATES;

EID: 0037048987     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Zarate CA Jr, Patel J. Sudden cardiac death and antipsychotic drugs: Do we know enough? Arch Gen Psychiatry 2001;58:1168-71.
2. National Center for Health Statistics. Ambulatory Care Drug Database System. www.cdc.gov/nchs/about/major/ahcd/ambulatory.htm (accessed 7 November 2001).
3. Reilly JG, Ayis SA, Ferrier IN. Jones SJ, Thomas SH. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000;355:1048-52.
4. Federal Drugs Administration Psychopharmacological Drugs Advisory Committee. Briefing Document for Zeldox Capsules, July 2000. www.fda.gov/ohrms/dockets/ac/00/backgrd/361961a.pdf (accessed 7 November 2001).
5. Margolis D, Bilker W, Hennessy S. Vittorio C, Santanna J, Strom BL. The risk of malignancy associated with psoriasis. Arch Dermatol 2001;137: 778-83.
6. Demailly P, Cambien F, Plouin PF, Baron P, Chevallier B. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica 1984;188:65-75.
7. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 Years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988;91:197-201.
8. Ray WA, Meredith S. Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001;58:1161-7.
9. British Medical Association, Royal Pharmaceutical Society of Great Britain. British national Formulary. London: BMA, RPS, 2001:172. (No 39).
10. Leuraud K, Benichou J. A comparison of several methods to test for the existence of a monotonic dose-response relationship in clinical and epidemiological studies. Stat Med 2001:20:3335-51.
11. Bhana N, Spencer CM. Risperidone: A review of its use in the management o f the behavioural and psychological symptoms of dementia. Drugs Aging 2000;16:451-71.
12. Buckley NA, Whyte IM, Dawson AH. Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol 1995;33:199-204.
13. Staffa. JA, Jones JK, Gable CB, Verspeelt JP, Amery WK Risk of selected serious cardiac events among new users of antihistamines. Clin Ther 1995:17:1062-77.